Real-world effectiveness and impact of the 4CMenB vaccine against serogroup B invasive meningococcal disease: a systematic review and meta-analysis

Abstract 4CMenB vaccine is authorized for protection against serogroup B invasive meningococcal disease (IMD). This study synthesized real-world evidence (RWE) data on effectiveness and impact of 4CMenB vaccine. A systematic search identified RWE on vaccine effectiveness (VE) and vaccine impact of 4...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Pavo Marijic, Katarzyna Jamróz-Dolińska, Wojciech Margas, Lucian Gaianu, Gaurav Mathur, Piotr Wojciechowski, Thatiana Pinto, Tia Vincent, Helen Petousis-Harris, Terry Nolan, Federico Martinón-Torres, Lee H. Harrison, Zeki Kocaata
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Nature Portfolio 2026-07-01
Saila:	npj Vaccines
Sarrera elektronikoa:	https://doi.org/10.1038/s41541-026-01511-y
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!